Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000010

Chief Scientific Officer sold 721 shares at $28.28 ($20,390)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lillie James Woodruff · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-07 Sale : show line 1 in the form 10b5-1 −721 $28.28 $20,390 242,729 D
Open-market sales · 721 sh · avg $28.28 · $20,390
Loading xslF345X06/form4-05112026_090501.xml…